Egidia Gabriela Miftode
Overview
Explore the profile of Egidia Gabriela Miftode including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miftode I, Vata A, Miftode R, Paranga T, Luca M, Manciuc C, et al.
Antibiotics (Basel)
. 2024 May;
13(5).
PMID: 38786190
Introduction: Antimicrobial resistance (AMR) is currently a growing concern among healthcare providers, underscoring the importance of describing the regional susceptibility profile for common microorganisms that are associated with urinary tract...
2.
Stamateanu L, Plesca C, Miftode I, Badescu A, Manciuc D, Hurmuzache M, et al.
Antibiotics (Basel)
. 2024 May;
13(5).
PMID: 38786189
infection (CDI), though identified nearly five decades ago, still remains a major challenge, being associated with significant mortality rates. The strains classified as hypervirulent, notably 027/NAP1/BI, have garnered substantial attention...
3.
Loghin I, Vata A, Miftode E, Cobaschi M, Rusu S, Silvas G, et al.
Clin Pract
. 2023 Dec;
13(6):1488-1500.
PMID: 38131680
Background And Objectives: One of the most severe forms of extrapulmonary tuberculosis (EPTB) is tuberculous meningitis (TBM), which is linked to significant morbidity and high mortality. It is well recognized...
4.
Stamateanu L, Miftode I, Plesca C, Dorneanu O, Rosu M, Miftode I, et al.
Antibiotics (Basel)
. 2023 Jul;
12(7).
PMID: 37508187
The Coronavirus disease 2019 (COVID-19) pandemic has brought new challenges across medical disciplines, particularly in infectious disease medicine. In Romania, the incidence of SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2)...
5.
Paranga T, Pavel-Tanasa M, Constantinescu D, Plesca C, Petrovici C, Miftode I, et al.
Front Immunol
. 2023 Jun;
14:1213246.
PMID: 37388734
C-reactive protein (CRP) has been one of the most investigated inflammatory-biomarkers during the ongoing COVID-19 pandemics caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The severe outcome among patients with...
6.
Trofin F, Nastase E, Rosu M, Badescu A, Buzila E, Miftode E, et al.
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37239895
The aim of this study was to analyze the serum concentration of interleukin-6 (IL-6), C-reactive protein (CRP), D-dimer, lactate dehydrogenase (LDH), ferritin, and procalcitonin in COVID-19 patients with different forms...
7.
Vata A, Rosu F, Dorneanu O, Lehaci A, Luca S, Loghin I, et al.
Medicina (Kaunas)
. 2023 Apr;
59(4).
PMID: 37109601
The intensive care unit (ICU), especially in an infectious disease hospital, is both an area with a high consumption of antibiotics (atb) and a "reservoir" of multidrug-resistant bacteria. We proposed...
8.
Erdem H, Baymakova M, Alkan S, Letaief A, Yahia W, Dayyab F, et al.
Eur J Clin Microbiol Infect Dis
. 2023 Feb;
42(4):387-398.
PMID: 36790531
Fever of unknown origin (FUO) is a serious challenge for physicians. The aim of the present study was to consider epidemiology and dynamics of FUO in countries with different economic...
9.
Timpau A, Miftode R, Costache I, Petris A, Miftode I, Gheorghe L, et al.
Antibiotics (Basel)
. 2023 Jan;
12(1).
PMID: 36671345
Background: Literature data on bacterial infections and their impact on the mortality rates of COVID-19 patients from Romania are scarce, while worldwide reports are contrasting. 2. Materials And Methods: We...
10.
Obreja M, Miftode E, Stoleriu I, Constantinescu D, Vata A, Leca D, et al.
Antibiotics (Basel)
. 2022 Jun;
11(6).
PMID: 35740230
The empirical administration of antibiotics for suspected bacterial meningitis denotes a poor bacterial stewardship. In this context, the use of biomarkers can distinguish between bacterial and viral infections before deciding...